Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

ImmunoGen narrows fiscal 1Q loss to $11.2 million
Yahoo/AP
Friday, October 25, 2013 - 9:37am
tags:
Immunogen, earnings
Earnings Preview: Merck to report 3Q results
Yahoo/AP
Thursday, October 24, 2013 - 6:06pm
tags:
Merck, earnings
J&J-Medivir Hepatitis C Pills Wins U.S. Panel Backing
Bloomberg
Thursday, October 24, 2013 - 6:04pm
tags:
FDA, JNJ, Medivir, hepatitis C, simeprevir
An FDA Panel Chair Talks To Industry Insiders About FDA Panels
Pharmalot
Thursday, October 24, 2013 - 12:15pm
tags:
FDA, advisory panels
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thursday, October 24, 2013 - 11:29am
tags:
Novo Nordisk, diabetes, Merck, Sanofi, NovoSeven, JNJ
2 Big Problems for GlaxoSmithKline
Motley Fool
Thursday, October 24, 2013 - 11:28am
tags:
GSK, China, Advair
FDA Approves First New Atherectomy Device In 20 Years
Forbes
Thursday, October 24, 2013 - 10:31am
tags:
FDA, atherectomy, devices, Diamondback 360, Cardiovascular Systems
FDA Grants Lilly's Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
Marketwatch
Thursday, October 24, 2013 - 10:29am
tags:
FDA, ramucirumab, Eli Lilly, gastric cancer
Teva ex-chairman: Execs should share layoffs pain with 10% pay cut
Fierce Pharma
Thursday, October 24, 2013 - 10:27am
tags:
executive pay, Teva, layoffs
Repros plummets as FDA questions testosterone drug data
Fierce Biotech
Thursday, October 24, 2013 - 10:26am
tags:
FDA, Repros Therapeutics, testosterone, Androxal
Zimmer slides on Q3 profit slide, narrowed guidance
Mass Device
Thursday, October 24, 2013 - 10:24am
tags:
Zimmer, earnings, devices
Bristol-Myers Squibb - There Is Life After Plavix
Seeking Alpha
Thursday, October 24, 2013 - 10:19am
tags:
Plavix, Bristol-Myers Squibb, JNJ, PFE
Mead Johnson profit rises as volumes grow in China, Hong Kong
Reuters
Thursday, October 24, 2013 - 10:18am
tags:
earnings, China, Hong Kong, Mead Johnson
Boston Scientific Will Cut 1,100-1,500 Jobs Through 2015
Bloomberg
Thursday, October 24, 2013 - 10:13am
tags:
layoffs, devices, Boston Scientific
Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals
Yahoo
Thursday, October 24, 2013 - 10:11am
tags:
Optimer Pharmaceuticals, M&A, Cubist Pharmaceuticals
Amarin Could Still Turn Profitable
Seeking Alpha
Thursday, October 24, 2013 - 10:03am
tags:
Amarin, Vascepa, GSK, Teva
Celgene's New Multiple Myeloma Drug Is Beating Amgen
TheStreet.com
Thursday, October 24, 2013 - 9:59am
tags:
Celgene, Multiple Myeloma, Amgen, Kyprolis, Pomalyst
Celgene profit lower; raises full-year forecast
Yahoo/Reuters
Thursday, October 24, 2013 - 9:56am
tags:
Celgene, earnings
McKesson Agrees to Buy Celesio for $5.4 Billion
Bloomberg
Thursday, October 24, 2013 - 8:49am
tags:
Celesio, McKesson, M&A
Rigel to drop skin disease drug after trial failure
Yahoo/Reuters
Thursday, October 24, 2013 - 8:47am
tags:
Rigel Pharmaceuticals, discoid lupus, R333

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.